Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5508256 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2017 | 46 Pages |
Abstract
The cells capacity to biosynthesize dihydroceramides must be taken into account in proautophagic Des1 inhibitors-including therapies.
Keywords
Des1CerS3MACCXγ-TocotrienolTBSTLC3γ-TSPTPXDDihydroceramide desaturaseDihydrosphingomyelinPVDFdhCerDHSM3-methyladenineγ-tocopherolAutophagysphingolipidssphingomyelinInhibitorDihydroceramideResveratrolCerceramideCancerCelecoxibceramide synthasePhenoxodiolLipidomicsMyrMyriocinmicrotubule-associated protein 1 light chain 3polyvinylidenedifluoride
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Mireia Casasampere, Yadira F. Ordóñez, Josefina Casas, Gemma Fabrias,